Filing Details
- Accession Number:
- 0001125345-17-000020
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2017-02-08 17:27:53
- Reporting Period:
- 2016-12-31
- Filing Date:
- 2017-02-08
- Accepted Time:
- 2017-02-08 17:27:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587487 | Marc Jon Wigginton | 9704 Medical Center Drive Rockville MD 20850 | Sr Vp, Clinical Dev. & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-10-03 | 10,000 | $29.34 | 30,000 | No | 5 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | S | Direct |
Footnotes
- Due to clerical error, the amount of securities beneficially owned after the transaction on 10/3/16 and reported on a Form 4 on 10/19/16, was incorrect. The corrected amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which vest on 2/25/18.